Bacille Calmette-Guerin immunotherapy of viral warts
Al-Mendalawi, M.D.; Sharquie, K.
Saudi Medical Journal 29(7): 1068; Author Reply 1068
2008
ISSN/ISBN: 0379-5284 PMID: 18626549 Document Number: 616380
Document emailed within 1 workday
Related Documents
Sharquie, K.E.; Al-Rawi, J.R.; Al-Nuaimy, A.A.; Radhy, S.H. 2008: Bacille Calmette-Guerin immunotherapy of viral warts Saudi Medical Journal 29(4): 589-593Freedman, S.O. 1979: Bacille Calmette--Guérin in cancer...therapy? Canadian Medical Association Journal 121(1): 13
Nissen, T.Nørrelykke.; Thøstesen, L.Marianne.; Birk, N.Marie.; Pihl, G.; Kjærgaard, J.; Stensballe, L.Graff. 2014: The bacille Calmette-Guérin vaccine may reduce the general child morbidity Ugeskrift for Laeger 176(9)
MacGregor, A.B.; Falk, R.E.; Landi, S.; Ambus, U.; Samuel, E.S.; Langer, B. 1977: Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin Canadian Journal of Surgery. Journal Canadien de Chirurgie 20(1): 25-30
Snider, T.G.; Pierce, K.R.; Adams, L.G. 1982: Response to neonatally thymectomized Holstein calves to bacille Calmette Guérin American Journal of Veterinary Research 43(8): 1363-1366
Smith, F.B.; Calmette, A.; Guérin, C. 1993: Tuberculosis and bureaucracy. Bacille Calmette et Guérin: its troubled path to acceptance in Britain and Australia Medical Journal of Australia 159(6): 408-411
Yin, H.-l.; Zhou, X.-j.; Wu, J.-p.; Meng, K.; Sun, Y.-m. 2004: Mycobacterial spindle cell pseudotumor of lymph nodes after receiving Bacille Calmette-Guerin (BCG) vaccination Chinese Medical Journal 117(2): 308-310
Basel, P.L.; Shrestha, I.B. 2012: Factors associated with dropout between Bacille Calmette Guerin (BCG) and measles vaccination in a village development committee of a district Journal of Nepal Health Research Council 10(21): 147-151
Dunkley-Thompson, J.; Pierre, R.B.; Steel-Duncan, J.; Palmer, P.; Davis, D.; Figueroa, J.P.; Christie, C.D.C. 2008: Bacille Calmette-Guérin lymphadenitis and immune reconstitution syndrome in HIV-infected children on antiretroviral therapy in Jamaica West Indian Medical Journal 57(3): 302-306
Lin, C.J.; Yang, W.S.; Yan, J.J.; Liu, C.C. 1999: Mycobacterium bovis osteomyelitis as a complication of Bacille Calmette-Guérin (BCG) vaccination: rapid diagnosis with use of DNA sequencing analysis: a case report Journal of Bone and Joint Surgery. American Volume 81(9): 1305-1311
Ryder, R.W.; Oxtoby, M.J.; Mvula, M.; Batter, V.; Baende, E.; Nsa, W.; Davachi, F.; Hassig, S.; Onorato, I.; Deforest, A. 1993: Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 Journal of Pediatrics 122(5 Part 1): 697-702
Brosman, S.A. 1992: Bacillus Calmette-Guérin immunotherapy. Techniques and results Urologic Clinics of North America 19(3): 557-564
Merrin, C.; Han, T.; Klein, E.; Wajsman, Z.; Murphy, G.P. 1975: Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin Cancer ChemoTherapy Reports 59(1): 157-163
Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
Lamm, D.L.; Harris, S.C.; Gittes, R.F. 1977: Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors Investigative Urology 14(5): 369-372
Sparks, F.C.; Breeding, J.H. 1974: Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase Cancer Research 34(12): 3262-3269
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Flam, T.A.; Chopin, D.K.; Leleu, C.; Abbou, C.C.; Steg, A.; Deslignères, S.; Boccon-Gibod, L. 1990: Immunohistochemical markers defined by monoclonal antibodies and response to bacillus Calmette-Guérin endovesical immunotherapy for superficial bladder tumors European Urology 17(4): 338-342
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405